UNITY BIOTECHNOLOGY INC - COM (UBX)

CUSIP: 91381U101

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
16,336,549
Share change
-236,793
Total reported value
$99,655,541
Price per share
$6.10
Number of holders
61
Value change
-$1,911,111
Number of buys
27
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 91381U101?
CUSIP 91381U101 identifies UBX - UNITY BIOTECHNOLOGY INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNITY BIOTECHNOLOGY INC - COM (UBX) as of Q3 2019

As of 30 Sep 2019, UNITY BIOTECHNOLOGY INC - COM (UBX) was held by 61 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,336,549 shares. The largest 10 holders included FMR LLC, BAILLIE GIFFORD & CO, BlackRock Inc., Capital World Investors, VANGUARD GROUP INC, STATE STREET CORP, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and MILLENNIUM MANAGEMENT LLC. This page lists 61 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.